Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
6.14
+0.35 (6.04%)
Feb 19, 2026, 2:30 PM EST - Market open

Kazia Therapeutics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
0.042.31--15.18
Other Revenue
1.790.1700.01-
Revenue
1.832.4800.0115.18
Revenue Growth (YoY)
-26.28%248000.00%-90.00%-99.93%1436.54%
Gross Profit
1.832.4800.0115.18
Selling, General & Admin
8.7213.568.585.247.02
Research & Development
7.3317.3815.5620.1714.54
Other Operating Expenses
----0.02-0
Operating Expenses
16.0530.9424.1525.3921.56
Operating Income
-14.22-28.46-24.15-25.38-6.38
Interest & Investment Income
0.070.010.0200.04
Other Non Operating Income (Expenses)
-2.481.28---
EBT Excluding Unusual Items
-16.62-27.17-24.12-25.38-6.34
Asset Writedown
-13.38----
Other Unusual Items
7.550.123.39--2.57
Pretax Income
-22.45-27.05-20.74-25.38-8.91
Income Tax Expense
-1.75-0.27-0.27-0.37-0.48
Earnings From Continuing Operations
-20.7-26.78-20.47-25.01-8.42
Net Income
-20.7-26.78-20.47-25.01-8.42
Net Income to Common
-20.7-26.78-20.47-25.01-8.42
Shares Outstanding (Basic)
11000
Shares Outstanding (Diluted)
11000
Shares Change (YoY)
107.81%43.08%39.12%12.57%61.08%
EPS (Basic)
-18.89-50.78-55.53-94.42-35.78
EPS (Diluted)
-18.89-50.78-55.53-94.42-35.80
Free Cash Flow
-13.28-9.58-15.16-22.76-9.11
Free Cash Flow Per Share
-12.12-18.17-41.12-85.92-38.71
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-777.31%-1147.20%-2414600.00%-253840.00%-42.01%
Profit Margin
-1131.88%-1079.32%-2046500.00%-250140.00%-55.47%
Free Cash Flow Margin
-725.97%-386.17%-1515600.00%-227620.00%-60.01%
EBITDA
-13.28-26.59-22.28-23.52-5.11
EBITDA Margin
-----33.68%
D&A For EBITDA
0.931.871.871.871.27
EBIT
-14.22-28.46-24.15-25.38-6.38
EBIT Margin
-----42.01%
Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q